My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$MU {{ '2016-10-04T20:51:00+0000' | timeago}} • Infographic

$MU Micron Technology Earnings Infographic: Q4 2016 Highlights.

User Ramesh Raju {{ '2017-01-24T08:15:35+0000' | timeago}}

For the combined company, CEO of Altimmune, Bill Enright and CFO of Altimmune, Elizabeth Czerepak, will continue to serve in their respective positions.

User Ramesh Raju {{ '2017-01-24T08:11:25+0000' | timeago}}

Upon completion of the transaction the combined company will trade under the new ticker symbol "ALT." The new company will be based in Gaithersburg, Maryland.

User Ramesh Raju {{ '2017-01-24T07:57:37+0000' | timeago}}

Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.

User Charles Elliston {{ '2017-01-23T20:14:24+0000' | timeago}}

A federal judge has upheld the DOJ’s decision to block the $AET-$HUM merger.

User Josh Allan {{ '2017-01-23T20:10:30+0000' | timeago}}

$YHOO is reporting today after market close. Nobody cares about this stock.

$DD {{ '2017-01-24T11:37:46+0000' | timeago}} • Announcement

$DD sees 1Q17 operating earnings to increase about 8% YoverY, driven by benefits from cost savings and the impact of the change in timing for seed deliveries, primarily related to the southern U.S. route-to-market change in Agriculture. These benefits are anticipated to be partially offset by the expected reduction in planted corn acres in the U.S.

$DD {{ '2017-01-24T11:37:21+0000' | timeago}} • Announcement

$DD expects the merger with $DOW to close in 1H17. For 1Q17, $DD expects GAAP earnings to decrease about 18% from last year. The company's GAAP earnings include an expected charge of about $0.15 per share for transaction costs associated with the planned merger with $DOW.

$DD {{ '2017-01-24T11:34:22+0000' | timeago}} • Announcement

$DD's sales for 4Q16 declined 2% YoverY, as a 1% benefit from currency was offset by a 2% decrease in local price and 1% decline in volume. Volume declined as growth in Performance Materials, Electronics & Communications and Industrial Biosciences was more than offset by declines in Agriculture, on timing of 4Q seed sales.

$DD {{ '2017-01-24T11:33:53+0000' | timeago}} • Announcement

$DD swung to a 4Q16 profit from a loss last year, driven by lower expenses despite a decline in sales. Net income was $263MM or $0.30 per share compared to a loss of $256MM or $0.29 per share last year. Net sales fell to $5.21Bil from $5.3Bil. Non-GAAP EPS increased to $0.51 from $0.27.

$PNFP {{ '2017-01-24T11:31:32+0000' | timeago}} • Announcement

$PNFP announced a proposed underwritten public offering of common shares to raise aggregate gross proceeds of $175MM. $PNFP plans to use proceeds to pay related fees and expenses; provide capital support for the growth of Pinnacle Bank, including in connection with its proposed acquisition of BNC Bancorp; and for other general corporate purposes.